The UK government is providing funding to bring a software tool used to monitor patients during surgery to market “as soon as possible”, says its developer.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS